2ckb › Citations

Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen.

Garcia KC, Degano M, Pease LR, Huang M, Peterson PA, Teyton L, Wilson IA
Science 279 1166-72 (1998)
Cited: 477 times
EuropePMC logo PMID: 9469799

Abstract

The T cell receptor (TCR) inherently has dual specificity. T cells must recognize self-antigens in the thymus during maturation and then discriminate between foreign pathogens in the periphery. A molecular basis for this cross-reactivity is elucidated by the crystal structure of the alloreactive 2C TCR bound to self peptide-major histocompatibility complex (pMHC) antigen H-2Kb-dEV8 refined against anisotropic 3.0 angstrom resolution x-ray data. The interface between peptide and TCR exhibits extremely poor shape complementarity, and the TCR beta chain complementarity-determining region 3 (CDR3) has minimal interaction with the dEV8 peptide. Large conformational changes in three of the TCR CDR loops are induced upon binding, providing a mechanism of structural plasticity to accommodate a variety of different peptide antigens. Extensive TCR interaction with the pMHC alpha helices suggests a generalized orientation that is mediated by the Valpha domain of the TCR and rationalizes how TCRs can effectively "scan" different peptides bound within a large, low-affinity MHC structural framework for those that provide the slight additional kinetic stabilization required for signaling.

Reviews - 2ckb mentioned but not cited (19)

  1. Evolutionarily conserved amino acids that control TCR-MHC interaction. Marrack P, Scott-Browne JP, Dai S, Gapin L, Kappler JW. Annu Rev Immunol 26 171-203 (2008)
  2. The molecular basis of TCR germline bias for MHC is surprisingly simple. Garcia KC, Adams JJ, Feng D, Ely LK. Nat Immunol 10 143-147 (2009)
  3. Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity. Selin LK, Brehm MA, Naumov YN, Cornberg M, Kim SK, Clute SC, Welsh RM. Immunol Rev 211 164-181 (2006)
  4. Human gamma delta T cells: Evolution and ligand recognition. Adams EJ, Gu S, Luoma AM. Cell Immunol 296 31-40 (2015)
  5. Conformational changes and flexibility in T-cell receptor recognition of peptide-MHC complexes. Armstrong KM, Piepenbrink KH, Baker BM. Biochem J 415 183-196 (2008)
  6. The structural basis of αβ T-lineage immune recognition: TCR docking topologies, mechanotransduction, and co-receptor function. Wang JH, Reinherz EL. Immunol Rev 250 102-119 (2012)
  7. TCR Recognition of Peptide-MHC-I: Rule Makers and Breakers. Szeto C, Lobos CA, Nguyen AT, Gras S. Int J Mol Sci 22 E68 (2020)
  8. Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells. Girardi E, Zajonc DM. Immunol Rev 250 167-179 (2012)
  9. Thermodynamics of T-cell receptor-peptide/MHC interactions: progress and opportunities. Armstrong KM, Insaidoo FK, Baker BM. J Mol Recognit 21 275-287 (2008)
  10. γδ T cell surveillance via CD1 molecules. Luoma AM, Castro CD, Adams EJ. Trends Immunol 35 613-621 (2014)
  11. Casting a wider net: Immunosurveillance by nonclassical MHC molecules. D'Souza MP, Adams E, Altman JD, Birnbaum ME, Boggiano C, Casorati G, Chien YH, Conley A, Eckle SBG, Früh K, Gondré-Lewis T, Hassan N, Huang H, Jayashankar L, Kasmar AG, Kunwar N, Lavelle J, Lewinsohn DM, Moody B, Picker L, Ramachandra L, Shastri N, Parham P, McMichael AJ, Yewdell JW. PLoS Pathog 15 e1007567 (2019)
  12. T cell receptor bias for MHC: co-evolution or co-receptors? Rangarajan S, Mariuzza RA. Cell Mol Life Sci 71 3059-3068 (2014)
  13. Coevolution of T-cell receptors with MHC and non-MHC ligands. Castro CD, Luoma AM, Adams EJ. Immunol Rev 267 30-55 (2015)
  14. Overview of protein structural and functional folds. Sun PD, Foster CE, Boyington JC. Curr Protoc Protein Sci Chapter 17 Unit 17.1 (2004)
  15. 50 Years of structural immunology. Wilson IA, Stanfield RL. J Biol Chem 296 100745 (2021)
  16. Presentation of lipid antigens by CD1 glycoproteins. Schiefner A, Wilson IA. Curr Pharm Des 15 3311-3317 (2009)
  17. The perception and response of T cells to a changing environment are based on the law of initial value. Huseby ES, Teixeiro E. Sci Signal 15 eabj9842 (2022)
  18. Unconventional Peptide Presentation by Classical MHC Class I and Implications for T and NK Cell Activation. Zajonc DM. Int J Mol Sci 21 E7561 (2020)
  19. Theoretical aspects of immunity. Deem MW, Hejazi P. Annu Rev Chem Biomol Eng 1 247-276 (2010)

Articles - 2ckb mentioned but not cited (27)



Reviews citing this publication (125)

  1. How TCRs bind MHCs, peptides, and coreceptors. Rudolph MG, Stanfield RL, Wilson IA. Annu Rev Immunol 24 419-466 (2006)
  2. CD1: antigen presentation and T cell function. Brigl M, Brenner MB. Annu Rev Immunol 22 817-890 (2004)
  3. Selecting and maintaining a diverse T-cell repertoire. Goldrath AW, Bevan MJ. Nature 402 255-262 (1999)
  4. T cell antigen receptor recognition of antigen-presenting molecules. Rossjohn J, Gras S, Miles JJ, Turner SJ, Godfrey DI, McCluskey J. Annu Rev Immunol 33 169-200 (2015)
  5. The HLA system. First of two parts. Klein J, Sato A. N Engl J Med 343 702-709 (2000)
  6. Molecular interactions mediating T cell antigen recognition. van der Merwe PA, Davis SJ. Annu Rev Immunol 21 659-684 (2003)
  7. Selection of the T cell repertoire. Sebzda E, Mariathasan S, Ohteki T, Jones R, Bachmann MF, Ohashi PS. Annu Rev Immunol 17 829-874 (1999)
  8. Structural basis of T cell recognition. Garcia KC, Teyton L, Wilson IA. Annu Rev Immunol 17 369-397 (1999)
  9. Why must T cells be cross-reactive? Sewell AK. Nat Rev Immunol 12 669-677 (2012)
  10. TCR Signaling: Mechanisms of Initiation and Propagation. Courtney AH, Lo WL, Weiss A. Trends Biochem Sci 43 108-123 (2018)
  11. The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation. Germain RN, Stefanová I. Annu Rev Immunol 17 467-522 (1999)
  12. The structural basis of T cell activation by superantigens. Li H, Llera A, Malchiodi EL, Mariuzza RA. Annu Rev Immunol 17 435-466 (1999)
  13. The specificity of TCR/pMHC interaction. Rudolph MG, Wilson IA. Curr Opin Immunol 14 52-65 (2002)
  14. How T cells 'see' antigen. Krogsgaard M, Davis MM. Nat Immunol 6 239-245 (2005)
  15. The nature of molecular recognition by T cells. Davis SJ, Ikemizu S, Evans EJ, Fugger L, Bakker TR, van der Merwe PA. Nat Immunol 4 217-224 (2003)
  16. T cell receptor-MHC interactions up close. Hennecke J, Wiley DC. Cell 104 1-4 (2001)
  17. Roles for glycosylation of cell surface receptors involved in cellular immune recognition. Rudd PM, Wormald MR, Stanfield RL, Huang M, Mattsson N, Speir JA, DiGennaro JA, Fetrow JS, Dwek RA, Wilson IA. J Mol Biol 293 351-366 (1999)
  18. Polyspecificity of T cell and B cell receptor recognition. Wucherpfennig KW, Allen PM, Celada F, Cohen IR, De Boer R, Garcia KC, Goldstein B, Greenspan R, Hafler D, Hodgkin P, Huseby ES, Krakauer DC, Nemazee D, Perelson AS, Pinilla C, Strong RK, Sercarz EE. Semin Immunol 19 216-224 (2007)
  19. Understanding the drivers of MHC restriction of T cell receptors. La Gruta NL, Gras S, Daley SR, Thomas PG, Rossjohn J. Nat Rev Immunol 18 467-478 (2018)
  20. How the T cell receptor sees antigen--a structural view. Garcia KC, Adams EJ. Cell 122 333-336 (2005)
  21. Genetically engineered T cells for cancer immunotherapy. Li D, Li X, Zhou WL, Huang Y, Liang X, Jiang L, Yang X, Sun J, Li Z, Han WD, Wang W. Signal Transduct Target Ther 4 35 (2019)
  22. Molecular interactions of coreceptor CD8 and MHC class I: the molecular basis for functional coordination with the T-cell receptor. Gao GF, Jakobsen BK. Immunol Today 21 630-636 (2000)
  23. Structural and biophysical determinants of αβ T-cell antigen recognition. Bridgeman JS, Sewell AK, Miles JJ, Price DA, Cole DK. Immunology 135 9-18 (2012)
  24. CD2 and the nature of protein interactions mediating cell-cell recognition. Davis SJ, Ikemizu S, Wild MK, van der Merwe PA. Immunol Rev 163 217-236 (1998)
  25. What do TCR-pMHC crystal structures teach us about MHC restriction and alloreactivity? Housset D, Malissen B. Trends Immunol 24 429-437 (2003)
  26. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition. Godfrey DI, Rossjohn J, McCluskey J. Immunity 28 304-314 (2008)
  27. Molecular coordination of alphabeta T-cell receptors and coreceptors CD8 and CD4 in their recognition of peptide-MHC ligands. Gao GF, Rao Z, Bell JI. Trends Immunol 23 408-413 (2002)
  28. Dynamics of cell surface molecules during T cell recognition. Davis MM, Krogsgaard M, Huppa JB, Sumen C, Purbhoo MA, Irvine DJ, Wu LC, Ehrlich L. Annu Rev Biochem 72 717-742 (2003)
  29. Cross-reactivity of T cells and its role in the immune system. Petrova G, Ferrante A, Gorski J. Crit Rev Immunol 32 349-372 (2012)
  30. Structural and thermodynamic correlates of T cell signaling. Rudolph MG, Luz JG, Wilson IA. Annu Rev Biophys Biomol Struct 31 121-149 (2002)
  31. A structural voyage toward an understanding of the MHC-I-restricted immune response: lessons learned and much to be learned. Gras S, Burrows SR, Turner SJ, Sewell AK, McCluskey J, Rossjohn J. Immunol Rev 250 61-81 (2012)
  32. The diversity of immunological synapses. Trautmann A, Valitutti S. Curr Opin Immunol 15 249-254 (2003)
  33. Perspective on antigen processing and presentation. Unanue ER. Immunol Rev 185 86-102 (2002)
  34. Exploring immunological specificity using synthetic peptide combinatorial libraries. Pinilla C, Martin R, Gran B, Appel JR, Boggiano C, Wilson DB, Houghten RA. Curr Opin Immunol 11 193-202 (1999)
  35. Genetic bases of autoimmune hepatitis. Czaja AJ, Doherty DG, Donaldson PT. Dig Dis Sci 47 2139-2150 (2002)
  36. Structural basis of molecular mimicry. Wucherpfennig KW. J Autoimmun 16 293-302 (2001)
  37. MHC superfamily structure and the immune system. Maenaka K, Jones EY. Curr Opin Struct Biol 9 745-753 (1999)
  38. Structural and dynamic control of T-cell receptor specificity, cross-reactivity, and binding mechanism. Baker BM, Scott DR, Blevins SJ, Hawse WF. Immunol Rev 250 10-31 (2012)
  39. Therapeutic Antibodies against Intracellular Tumor Antigens. Trenevska I, Li D, Banham AH. Front Immunol 8 1001 (2017)
  40. The molecular basis of CD1-mediated presentation of lipid antigens. Moody DB, Besra GS, Wilson IA, Porcelli SA. Immunol Rev 172 285-296 (1999)
  41. Interactions between MHC molecules and co-receptors of the TCR. König R. Curr Opin Immunol 14 75-83 (2002)
  42. Structural basis of T cell recognition of peptides bound to MHC molecules. Wang JH, Reinherz EL. Mol Immunol 38 1039-1049 (2002)
  43. Use of baculovirus MHC/peptide display libraries to characterize T-cell receptor ligands. Crawford F, Jordan KR, Stadinski B, Wang Y, Huseby E, Marrack P, Slansky JE, Kappler JW. Immunol Rev 210 156-170 (2006)
  44. Emerging Concepts in TCR Specificity: Rationalizing and (Maybe) Predicting Outcomes. Singh NK, Riley TP, Baker SCB, Borrman T, Weng Z, Baker BM. J Immunol 199 2203-2213 (2017)
  45. T cell receptor recognition of self and foreign antigens in the induction of autoimmunity. Wucherpfennig KW, Sethi D. Semin Immunol 23 84-91 (2011)
  46. T cells and their eons-old obsession with MHC. Yin L, Scott-Browne J, Kappler JW, Gapin L, Marrack P. Immunol Rev 250 49-60 (2012)
  47. The influence of antiviral T-cell responses on the alloreactive repertoire. Burrows SR, Khanna R, Silins SL, Moss DJ. Immunol Today 20 203-207 (1999)
  48. Emerging techniques for investigating molecular interactions at lipid membranes. Heyse S, Stora T, Schmid E, Lakey JH, Vogel H. Biochim Biophys Acta 1376 319-338 (1998)
  49. Conservation and diversification of MHC class I and its related molecules in vertebrates. Hashimoto K, Okamura K, Yamaguchi H, Ototake M, Nakanishi T, Kurosawa Y. Immunol Rev 167 81-100 (1999)
  50. A role for "self" in T-cell activation. Krogsgaard M, Juang J, Davis MM. Semin Immunol 19 236-244 (2007)
  51. Luxury accommodations: the expanding role of structural plasticity in protein-protein interactions. Sundberg EJ, Mariuzza RA. Structure 8 R137-42 (2000)
  52. Preferential expression of TCR V alpha regions in CD4/CD8 subsets: class discrimination or co-receptor recognition? Sim BC, Lo D, Gascoigne NR. Immunol Today 19 276-282 (1998)
  53. Structure-Based, Rational Design of T Cell Receptors. Zoete V, Irving M, Ferber M, Cuendet MA, Michielin O. Front Immunol 4 268 (2013)
  54. So many ways of getting in the way: diversity in the molecular architecture of superantigen-dependent T-cell signaling complexes. Sundberg EJ, Li Y, Mariuzza RA. Curr Opin Immunol 14 36-44 (2002)
  55. The structure, organization, activation and plasticity of the erythropoietin receptor. Wilson IA, Jolliffe LK. Curr Opin Struct Biol 9 696-704 (1999)
  56. An evolutionary and structural perspective on T cell antigen receptor function. Malissen B. Immunol Rev 191 7-27 (2003)
  57. Display, engineering, and applications of antigen-specific T cell receptors. Richman SA, Kranz DM. Biomol Eng 24 361-373 (2007)
  58. The two-signal model of T-cell activation after 30 years. Bernard A, Lamy And L, Alberti I. Transplantation 73 S31-5 (2002)
  59. Linking molecular and cellular events in T-cell activation and synapse formation. Krogsgaard M, Huppa JB, Purbhoo MA, Davis MM. Semin Immunol 15 307-315 (2003)
  60. The immunology of Epstein-Barr virus infection. Moss DJ, Burrows SR, Silins SL, Misko I, Khanna R. Philos Trans R Soc Lond B Biol Sci 356 475-488 (2001)
  61. Modulation of T cell function by TCR/pMHC binding kinetics. Carreño LJ, González PA, Kalergis AM. Immunobiology 211 47-64 (2006)
  62. T-cell allorecognition: a case of mistaken identity or déjà vu? Archbold JK, Macdonald WA, Burrows SR, Rossjohn J, McCluskey J. Trends Immunol 29 220-226 (2008)
  63. The structural bases of direct T-cell allorecognition: implications for T-cell-mediated transplant rejection. Gras S, Kjer-Nielsen L, Chen Z, Rossjohn J, McCluskey J. Immunol Cell Biol 89 388-395 (2011)
  64. A model T-cell receptor system for studying memory T-cell development. Chen J, Eisen HN, Kranz DM. Microbes Infect 5 233-240 (2003)
  65. Specificity on a knife-edge: the alphabeta T cell receptor. Clements CS, Dunstone MA, Macdonald WA, McCluskey J, Rossjohn J. Curr Opin Struct Biol 16 787-795 (2006)
  66. Transitioning from Idiopathic to Explainable Autoimmune Hepatitis. Czaja AJ. Dig Dis Sci 60 2881-2900 (2015)
  67. Unusual features of self-peptide/MHC binding by autoimmune T cell receptors. Nicholson MJ, Hahn M, Wucherpfennig KW. Immunity 23 351-360 (2005)
  68. Persisting viruses and chronic inflammation: understanding their relation to autoimmunity. Di Rosa F, Barnaba V. Immunol Rev 164 17-27 (1998)
  69. Understanding the complexity and malleability of T-cell recognition. Miles JJ, McCluskey J, Rossjohn J, Gras S. Immunol Cell Biol 93 433-441 (2015)
  70. Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity? Garbelli S, Mantovani S, Palermo B, Giachino C. Pigment Cell Res 18 234-242 (2005)
  71. T cell receptor mimic antibodies for cancer therapy. Dubrovsky L, Dao T, Gejman RS, Brea EJ, Chang AY, Oh CY, Casey E, Pankov D, Scheinberg DA. Oncoimmunology 5 e1049803 (2016)
  72. TCR-MHC docking orientation: natural selection, or thymic selection? Collins EJ, Riddle DS. Immunol Res 41 267-294 (2008)
  73. Antiviral memory phenotype T cells in unexposed adults. Su LF, Davis MM. Immunol Rev 255 95-109 (2013)
  74. Diversity-oriented approaches for interrogating T-cell receptor repertoire, ligand recognition, and function. Birnbaum ME, Dong S, Garcia KC. Immunol Rev 250 82-101 (2012)
  75. Role of autoreactive CD8+ T cells in organ-specific autoimmune diseases: insight from transgenic mouse models. Vizler C, Bercovici N, Cornet A, Cambouris C, Liblau RS. Immunol Rev 169 81-92 (1999)
  76. Structure and function of natural-killer-cell receptors. Sun PD. Immunol Res 27 539-548 (2003)
  77. T-cells behaving badly: structural insights into alloreactivity and autoimmunity. Ely LK, Burrows SR, Purcell AW, Rossjohn J, McCluskey J. Curr Opin Immunol 20 575-580 (2008)
  78. Mechanisms controlling granule-mediated cytolytic activity of cytotoxic T lymphocytes. Anikeeva N, Sykulev Y. Immunol Res 51 183-194 (2011)
  79. Recognition of self and altered self by T cells in autoimmunity and allergy. Yin L, Dai S, Clayton G, Gao W, Wang Y, Kappler J, Marrack P. Protein Cell 4 8-16 (2013)
  80. Structural basis of cell-cell interactions in the immune system. Wang J, Reinherz EL. Curr Opin Struct Biol 10 656-661 (2000)
  81. CD8 T cell responses to viral infections in sequence. Brehm MA, Selin LK, Welsh RM. Cell Microbiol 6 411-421 (2004)
  82. Binding energetics of T-cell receptors: correlation with immunological consequences. Manning TC, Kranz DM. Immunol Today 20 417-422 (1999)
  83. Cross-reactivity in T-cell antigen recognition. Regner M. Immunol Cell Biol 79 91-100 (2001)
  84. Probing the activation requirements for naive CD8+ T cells with Drosophila cell transfectants as antigen presenting cells. Cai Z, Brunmark AB, Luxembourg AT, Garcia KC, Degano M, Teyton L, Wilson I, Peterson PA, Sprent J, Jackson MR. Immunol Rev 165 249-265 (1998)
  85. Structure-function studies of T-cell receptor-superantigen interactions. Li H, Llera A, Mariuzza RA. Immunol Rev 163 177-186 (1998)
  86. An in depth analysis of the concept of "polyspecificity" assumed to characterize TCR/BCR recognition. Cohn M. Immunol Res 40 128-147 (2008)
  87. T cell receptor specificity for major histocompatibility complex proteins. Marrack P, Rubtsova K, Scott-Browne J, Kappler JW. Curr Opin Immunol 20 203-207 (2008)
  88. Molecular interactions between extracellular components of the T-cell receptor signaling complex. Garcia KC. Immunol Rev 172 73-85 (1999)
  89. Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis. Offner H, Sinha S, Wang C, Burrows GG, Vandenbark AA. Rev Neurosci 19 327-339 (2008)
  90. Structural understanding of T cell receptor triggering. Xu X, Li H, Xu C. Cell Mol Immunol 17 193-202 (2020)
  91. What Is Direct Allorecognition? Boardman DA, Jacob J, Smyth LA, Lombardi G, Lechler RI. Curr Transplant Rep 3 275-283 (2016)
  92. Quantitative theories of T-cell responsiveness. van den Berg HA, Rand DA. Immunol Rev 216 81-92 (2007)
  93. T-cell-receptor cross-recognition and strategies to select safe T-cell receptors for clinical translation. Bentzen AK, Hadrup SR. Immunooncol Technol 2 1-10 (2019)
  94. The versatility of the αβ T-cell antigen receptor. Bhati M, Cole DK, McCluskey J, Sewell AK, Rossjohn J. Protein Sci 23 260-272 (2014)
  95. Recognition surfaces of MHC class I. Jones EY, Tormo J, Reid SW, Stuart DI. Immunol Rev 163 121-128 (1998)
  96. TCR clonotypes: molecular determinants of T-cell efficacy against HIV. Lissina A, Chakrabarti LA, Takiguchi M, Appay V. Curr Opin Virol 16 77-85 (2016)
  97. Altered peptide ligand design: altering immune responses to class I MHC/peptide complexes. Collins EJ, Frelinger JA. Immunol Rev 163 151-160 (1998)
  98. T cell receptor repertoire usage in allotransplantation: an overview. Douillard P, Cuturi MC, Brouard S, Josien R, Soulillou JP. Transplantation 68 913-921 (1999)
  99. Tumor-associated antigens and biomarkers in cancer and immune therapy. Malyankar UM. Int Rev Immunol 26 223-247 (2007)
  100. Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells. Wahl A, Weidanz J, Hildebrand W. Expert Rev Proteomics 3 641-652 (2006)
  101. Minor histocompatibility antigens: presentation principles, recognition logic and the potential for a healing hand. Spencer CT, Gilchuk P, Dragovic SM, Joyce S. Curr Opin Organ Transplant 15 512-525 (2010)
  102. The intersection of affinity and specificity in the development and optimization of T cell receptor based therapeutics. Riley TP, Baker BM. Semin Cell Dev Biol 84 30-41 (2018)
  103. Differential signalling by variant ligands of the T cell receptor and the kinetic model of T cell activation. Madrenas J. Life Sci 64 717-731 (1999)
  104. Mouse Models of Heterologous Flavivirus Immunity: A Role for Cross-Reactive T Cells. Hassert M, Brien JD, Pinto AK. Front Immunol 10 1045 (2019)
  105. Kinetic evolution of a diabetogenic CD8+ T cell response. Santamaria P. Ann N Y Acad Sci 1005 88-97 (2003)
  106. A tale of two T cells. Janeway CA. Immunity 8 391-394 (1998)
  107. Immunological Mechanisms of Metal Allergies and the Nickel-Specific TCR-pMHC Interface. Riedel F, Aparicio-Soto M, Curato C, Thierse HJ, Siewert K, Luch A. Int J Environ Res Public Health 18 10867 (2021)
  108. Structural, biochemical, and biophysical studies of HLA-A2/altered peptide ligands binding to viral-peptide-specific human T-cell receptors. Baker BM, Ding YH, Garboczi DN, Biddison WE, Wiley DC. Cold Spring Harb Symp Quant Biol 64 235-241 (1999)
  109. Thymoproteasome and peptidic self. Takahama Y, Ohigashi I, Murata S, Tanaka K. Immunogenetics 71 217-221 (2019)
  110. Antigen specificity of semi-invariant CD1d-restricted T cell receptors: the best of both worlds? Gumperz JE. Immunol Cell Biol 82 285-294 (2004)
  111. The use of soluble synthetic peptide combinatorial libraries to determine antigen recognition of T cells. Hemmer B, Pinilla C, Appel J, Pascal J, Houghten R, Martin R. J Pept Res 52 338-345 (1998)
  112. Antigen presenting cells integrate opposing signals from CD4+ and CD8+ regulatory T lymphocytes to arbitrate the outcomes of immune responses. Lederman S, Suciu-Foca N. Hum Immunol 60 533-561 (1999)
  113. T-cell receptor peptide-MHC interactions: biological lessons from structural studies. Garcia KC, Teyton L. Curr Opin Biotechnol 9 338-343 (1998)
  114. Immunobiology of stiff-person syndrome. Raju R, Hampe CS. Int Rev Immunol 27 79-92 (2008)
  115. Thymocyte selection in Vav and IRF-1 gene-deficient mice. Penninger JM, Mak TW. Immunol Rev 165 149-166 (1998)
  116. Self-peptide/MHC and TCR antagonism: physiological role and therapeutic potential. Vukmanović S, Santori FR. Cell Immunol 233 75-84 (2005)
  117. T cell receptor binding kinetics and special role of Valpha in T cell development and activation. Gascoigne NR, Alam SM, Lin CM, McGuire MV, Marine S, Niederberger N, Redpath S, Sim BC, Travers PJ, Yachi P, Zal MA, Zal T. Immunol Res 21 225-231 (2000)
  118. Recent advances in immunology in multiple sclerosis. Liblau RS, Fontaine B. Curr Opin Neurol 11 293-298 (1998)
  119. T-cell activation pathways: a transplantation perspective. Halloran PF. Transplant Proc 31 769-771 (1999)
  120. Function and dysfunction of T cell receptor: structural studies. Teyton L, Apostolopoulos V, Cantu C, Celia H, Mallet-Désigné V, Stefanko R, Stramann T, Wallace M. Immunol Res 21 325-330 (2000)
  121. Self peptides and the peptidic self. Kourilsky P, Fazilleau N. Int Rev Immunol 20 575-591 (2001)
  122. Pre-existing T Cell Memory to Novel Pathogens. Afroz S, Bartolo L, Su LF. Immunohorizons 7 543-553 (2023)
  123. Recombinant T-cell receptors: an immunologic link to cancer therapy. Calogero A, de Leij LF, Mulder NH, Hospers GA. J Immunother 23 393-400 (2000)
  124. Strategies and rules for tuning TCR-derived therapy. Mo G, Lu X, Wu S, Zhu W. Expert Rev Mol Med 26 e4 (2023)
  125. T Cell Receptor Chain Centricity: The Phenomenon and Potential Applications in Cancer Immunotherapy. Kalinina AA, Khromykh LM, Kazansky DB. Int J Mol Sci 24 15211 (2023)

Articles citing this publication (306)



Related citations provided by authors (1)

Quick links